Skip to main content
OpenTrials
Completed

NCT Number: NCT07643142

Diagnostic Performance of Serum Calprotectin in Acute Appendicitis

This prospective observational study evaluated the diagnostic performance of serum calprotectin in patients presenting with acute abdominal pain and suspected acute appendicitis. Patients with histopathologically confirmed acute appendicitis were compared with patients diagnosed with nonspecific abdominal pain. Serum calprotectin levels were analyzed and compared with conventional inflammatory markers and the Alvarado score to assess their diagnostic value in acute appendicitis.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Fatih Sultan Mehmet Training and Research Hospital

Istanbul, ATASEHIR, 34752, Turkey (Türkiye)

About this study

Acute appendicitis is one of the most common causes of acute abdominal pain requiring emergency surgical intervention. However, establishing an accurate diagnosis may be difficult, particularly in patients presenting with nonspecific abdominal pain or atypical clinical findings. Conventional inflammatory markers and clinical scoring systems are useful adjuncts, but their diagnostic accuracy remains limited.

This prospective single-center observational study evaluated the diagnostic performance of serum calprotectin in adult patients presenting with acute abdominal pain and suspected acute appendicitis. Patients with histopathologically confirmed acute appendicitis were compared with a control group consisting of patients diagnosed with nonspecific abdominal pain after clinical, laboratory, radiological evaluation, and follow-up.

Serum calprotectin concentrations were measured and compared with white blood cell count, C-reactive protein, ferritin, and the Alvarado score. The relationship between serum calprotectin levels and histopathological severity of appendicitis was also assessed.

The primary objective of the study was to determine the diagnostic accuracy of serum calprotectin in distinguishing acute appendicitis from nonspecific abdominal pain.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age between 18 and 75 years
  • Presentation to the emergency department with acute abdominal pain and suspected acute appendicitis
  • Willingness to participate and provide informed consent

Exclusion criteria

  • Previous abdominal surgery
  • Chronic inflammatory or autoimmune disease
  • Active infection other than suspected appendicitis
  • Use of systemic anti-inflammatory or immunosuppressive therapy
  • Pregnancy
  • Incomplete clinical or laboratory data

Treatment and study plan

Serum Calprotectin Measurement

Diagnostic Test

Measurement of serum calprotectin levels using ELISA for diagnostic evaluation of acute appendicitis.

Primary outcomes

  1. Diagnostic accuracy of serum calprotectin for acute appendicitis

    Time frame: At admission to the emergency department

    Comparison of serum calprotectin levels between patients with acute appendicitis and nonspecific abdominal pain.

Sponsors and collaborators

Lead sponsor

Fatih Sultan Mehmet Training and Research Hospital

Other

Registry information

Official study title

Diagnostic Performance of Serum Calprotectin in Acute Appendicitis: A Prospective Comparative Analysis Study

Acronym: SCP-AA

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Jun 11, 2026
Registry last updated
Jun 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.